GnuBIO, Inc Awarded $4.5 Million in Funding From the National Human Genome Research Institute to Develop Lower Cost Genome Sequencing Technology With Greater Speed and Accuracy  
9/19/2012 10:12:54 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--GnuBIO announced today that it has been awarded a $4.5 million Phase II SBIR grant over the next three years through the National Human Genome Research Institute’s (NHGRI) Advanced DNA Sequencing Technology Program. After a rigorous process, the grant committee at the NIH chose six projects to fund for this competitive award’s program aimed at further advancing DNA sequencing technologies. Out of the total of $19 million, the NHGRI awarded GnuBIO the largest annual amount.